Ispire Secures Malaysia’s First Nicotine Manufacturing License, Plans to Expand to 80 Production Lines

May.23.2025
Ispire has won Malaysia’s first—and only—provisional nicotine manufacturing license, giving it sole rights to make, import and export nicotine products. The company plans to scale up from 6 to 80 production lines and build a global supply chain to reduce geopolitical risks.

Key Points:

 

1.Ispire has obtained Malaysia's first and only nicotine product manufacturing license approved by both the federal and state governments.

 

2.Ispire will begin production and promotion of its nicotine products in Malaysia, and plans to increase the country's production lines from the current six to 80.

 

3.Ispire claims to be the only company in the country with full authorization for exporting, importing, and manufacturing.

 


 

According to a statement on the Ispire website on May 22nd, Ispire Technology Inc (Ispire) has announced that it has been granted a temporary license by the Malaysian government to manufacture nicotine products.

 

Ispire stated that the license is currently the first and only nicotine product manufacturing license approved by the federal and state governments in Malaysia, cementing Ispire's position as the only company in the country with full export, import, and production authorization.

 

Chief Executive Officer Michael Wang said that obtaining this temporary license is an important step for the company to move towards becoming a leading international e-cigarette hardware supplier. Ispire immediately began production and promotion of its nicotine products in Malaysia, with plans to increase the production lines from the current 6 to 80.

 

"We will meet regulatory requirements in Malaysia, and Ispire will be granted the country's first federal nicotine manufacturing license. By diversifying our production base, we are strategically reducing production risks and alleviating concerns about price increases due to geopolitical factors," said Michael Wang.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
NJOY and Altria ask federal court to halt ITC proceeding, alleging multiple constitutional defects
NJOY and Altria ask federal court to halt ITC proceeding, alleging multiple constitutional defects
A filing in the U.S. District Court for the Eastern District of Virginia (Richmond Division) shows NJOY and Altria entities submitted a plaintiffs’ reply supporting their motion for summary judgment, arguing the challenged ITC proceeding is unconstitutional on multiple grounds, including ALJ appointment authority, removal protections, and Article III limits under the Jarkesy framework. The plaintiffs seek summary judgment and a permanent injunction barring continuation of the ITC proceeding.
Jan.08 by 2FIRSTS.ai
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape launches Labster production unit for e-liquids and DIY concentrates
Kumulus Vape has launched Labster, a 700 sq m production unit in the Lyon Metropolis near the group’s headquarters, for e-liquids and DIY concentrates. The site is equipped with automated lines supplied by CDA (Constructions d’Automatismes) to carry out bottling and labeling. Its theoretical capacity is described as several million bottles per year in 10–100 ml formats, and it is already operational.
Feb.06 by 2FIRSTS.ai
Philippine Lawmakers Push Bill to Close Vape Tax Loopholes
Philippine Lawmakers Push Bill to Close Vape Tax Loopholes
Lawmakers in the Philippines are pushing House Bill 5207 (HB 5207), which seeks to harmonize excise tax rates on vapor products and address disparities between nicotine salt and freebase nicotine taxation. The bill, supported by more than 40 lawmakers including Deputy Speaker Kristine Singson-Meehan, would raise taxes on freebase nicotine products to align them with nicotine salt rates.
Regulations
Feb.22
Vietnam Ho Chi Minh City police seize 28,657 illegal vape-related products worth over US$182,400
Vietnam Ho Chi Minh City police seize 28,657 illegal vape-related products worth over US$182,400
Police in Ho Chi Minh City, Vietnam say they dismantled a large illegal vape distribution ring led by 29-year-old Nguyễn Ngọc Quốc Uy, who allegedly built a concealed “secret room” to hide contraband. Officers seized 28,657 items valued at more than VND 4.8 billion (about US$182,400).
Feb.04 by 2FIRSTS.ai
Daegu Jung-gu: liquid e-cigarettes with synthetic nicotine to be fined in nonsmoking areas under revised Tobacco Business Act
Daegu Jung-gu: liquid e-cigarettes with synthetic nicotine to be fined in nonsmoking areas under revised Tobacco Business Act
Daegu’s Jung-gu District announced on Feb. 10 that, following amendments to the Tobacco Business Act that explicitly classify liquid e-cigarettes containing synthetic nicotine as “tobacco” (effective April 24, 2026), the district will expand regulations to include fines for vaping such products in designated nonsmoking areas. The district health office said smokers/vapers could face an administrative fine of up to 100,000 won for using synthetic-nicotine liquid e-cigarettes in smoke-free zones
Feb.10 by 2FIRSTS.ai